NVE Corporation is a Minnesota spintronics specialist whose opening fiscal quarter recasts a long-flat product franchise as a possible growth story, just as the founder-era chief executive hands the operating seat to the longtime technology head. Revenue jumped 81 percent to $11 million as new catalog devices and a firmer semiconductor cycle lifted both defense and commercial channels. The print arrived weeks before Daniel Baker retired as president and chief executive at the August shareholder meeting, with Peter Eames taking the chair after two decades inside the lab and the fab. The investment debate is whether that surge is a durable mix shift or a one-quarter restock on a still-concentrated, high-payout micro-cap.
The same quarter that covered the regular cash dividend from earnings also showed how thin the cash buffer has become after years of payouts above reported profit. Operating cash still cleared the quarterly distribution. Receivables nearly doubled as shipments outran collections, and the securities book remains the backstop if growth fades. Baker credited new product sales and a strong semiconductor market, which is the bull case in one clause. The counterargument is that the prior fiscal year barely grew after a cycle hangover, and one medical-device relationship still sits under a supplier agreement that expires at year-end 2027.
Net income rose 79 percent. Diluted earnings reached $1.32 a share on an operating margin that widened even as research staffing and performance pay climbed. The completed Eden Prairie expansion is now a depreciation line rather than a cash drain. The next several quarters decide whether Eames inherits a new run-rate or a restocking spike, and whether the board keeps a four-dollar annual dividend that the securities portfolio has been helping to fund. Does product breadth persist once the easy comparisons fade?